RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEW64D02D0402F9E9FA
https://w3id.org/ripe/ripe-kg/work/RIPEW64D02D0402F9E9FA
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.eururo.2013.04.001OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
dcterms:title |
Funding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
rdf:type |
node1 |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
rdf:type |
owl:Thing |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
rdf:type |
prov:Entity |
ripekg:work/RIPEW64D02D0402F9E9FAFunding/Support and role of the sponsor: Allergan, Inc. helped design and conduct the study; collect, manage, analyse, and interpret the data; and prepare, review, and approve the manuscript. Acknowledgement statement: The authors acknowledge Jennifer L. Giel, PhD, of Evidence Scientific Solutions |
rdf:type |
ripe:WorkWork |